This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Otsuka Pharmaceutical Factory, Inc., Otsuka Pharmaceutical Company, Limited, Senju Pharmaceutical Co., Ltd.. Active years: 1998-2006.
Location History:
- Tokushima, JP (1998)
- Naruto, JP (2001 - 2006)
Company Filing History:
3 out of 192 
1 out of 846 
1 out of 229 Years Active: 1998-2006
Title: Seiichiro Iguchi: Innovator in Ocular Solutions
Introduction
Seiichiro Iguchi is a notable inventor based in Naruto, Japan. He has made significant contributions to the field of ocular solutions, holding a total of 4 patents. His innovative work focuses on improving the packaging and delivery of ocular irrigating solutions.
Latest Patents
Iguchi's latest patents include a method of packaging ocular irrigating solutions. This invention features a gas-permeable plastic multiple compartment bag, which is enclosed in a gas-impermeable plastic packaging member. One compartment contains an oxiglutatione-containing solution or solid preparation, while another compartment holds a bicarbonate ion solution. The space between the bag and the packaging member is filled with a carbon dioxide gas atmosphere. Another patent involves a packaged ophthalmic perfusate and cleaning fluid bag, which shares similar characteristics and benefits.
Career Highlights
Throughout his career, Seiichiro Iguchi has worked with prominent companies such as Otsuka Pharmaceutical Factory, Inc. and Otsuka Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in ocular solutions.
Collaborations
Iguchi has collaborated with notable coworkers, including Katsuhiro Inada and Mitsuhira Nishio. Their combined expertise has contributed to the advancement of ocular solutions and the successful development of Iguchi's patents.
Conclusion
Seiichiro Iguchi's contributions to ocular solutions through his innovative patents demonstrate his commitment to improving medical technology. His work continues to impact the field positively, enhancing the delivery and effectiveness of ocular treatments.